What is the latest RUBICON stock price?
The latest stored price for RUBICON is Rs 1,672.60 as of 2026-11-16.
RUBICON RESEARCH LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available RUBICON price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for RUBICON is Rs 1,672.60 as of 2026-11-16.
RUBICON is above 50DMA, above 200DMA. The latest 50DMA is 1,648.91 and the latest 200DMA is 1,253.66.
RUBICON has PE 84.84, ROE +25.20%, and ROCE +28.59% in Gimli's latest available snapshot.
RUBICON has returned +10.87% over 1 month, +3.30% over 3 months, and +134.32% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 576.38 cr | 146.37 cr | 90.48 cr | 5.47 |
| 2026-06-30 | 534.34 cr | 134.80 cr | 84.78 cr | 5.13 |
| 2026-03-31 | 513.91 cr | 121.31 cr | 76.78 cr | 4.66 |
| 2025-12-31 | 475.53 cr | 111.91 cr | 72.80 cr | 4.46 |
| 2025-09-30 | 412.72 cr | 94.99 cr | 53.85 cr | 3.27 |
| 2025-06-30 | 353.12 cr | 79.74 cr | 43.30 cr | nan |
| 2025-03-31 | 358.15 cr | 72.57 cr | 36.24 cr | 2.20 |
| 2024-12-31 | 313.40 cr | 70.39 cr | 38.07 cr | 2.31 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 1,753.96 cr | 407.96 cr | 246.74 cr | 15.52 |
| 2025-03-31 | 1,284.27 cr | 267.89 cr | 167.54 cr | nan |
| 2024-03-31 | 656.94 cr | 99.55 cr | 24.35 cr | 1.58 |
| 2023-03-31 | 419.00 cr | 43.97 cr | -16.89 cr | -1.11 |
| 2022-03-31 | 417.41 cr | 57.45 cr | 16.68 cr | 32.91 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 2,326.71 cr | 185.65 cr | 311.01 cr | 1,288.82 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 205.05 cr | -24.12 cr | n/a |
| 2025-03-31 | n/a | n/a | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +51.25% | +9.01% | +15.72% | +13.78% | +24.02% | +0.00% |
| 2026-06-30 | +59.76% | +7.52% | +9.43% | +7.23% | +23.30% | +0.00% |
| 2026-03-31 | +59.86% | +7.54% | +10.02% | +7.14% | +22.58% | +0.00% |
| 2025-12-31 | +59.99% | +7.99% | +9.45% | +6.61% | +22.57% | +0.00% |
| 2025-10-15 | +59.99% | +9.37% | +10.54% | +5.63% | +20.10% | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.